Considering multiple alterations in HDM and HMT genes in cancer cells, it seems that using this approach could yield new functional connections between histone modifying enzymes, which might be helpful in designing a combination cancer therapy

imarily 15198639" in vascular endothelial cells as well as epithelial and smooth muscle cells throughout the body. Early clinical manifestations of the disease include angiokeratoma, acroparesthesias, episodic pain "crises'', hypohydrosis,…